Pharma in india

Megatrend biologics

According to current market reports, drug expenses will amount to 1.5 trillion US dollars globally in 2021. Biological substances are an important driver – and have become one of the main trends in the pharmaceutical industry, spreading to more and more regions and people. …more


Packaging Services completes Bosch’s system competence

Customized services for all maintenance strategies
A comprehensive range of services to improve machine efficiency and productivity completes Bosch’s system and line competence. The focus at interpack 2017 is on solutions for preventive maintenance as well as services to eliminate unwanted machine conditions as quickly as possible. …more



Industry 4.0 live at Interpack

People, machines, processes, superordinate IT – everything and everyone is connected in the factory of the future. But which specific advantages does Industry 4.0 offer for process and packaging technology? At interpack 2017, visitors to Bosch’s booth can experience live, how higher production transparency increases productivity, quality and efficiency in day-to-day work. …more



Successful launch: FLT 1000 with isolator

Bosch FLT isolator

Visitors to Pharma Expo 2016 in Chicago, Illinois, saw the successful launch of the fully automated FLT vial filling and closing machine. It is the most recent addition to the highly flexible FLT product family. For the first time, this machine was now showcased with an isolator.

 

…more


The changing roles in pharma

The pharma industry is rapidly changing

The pharmaceutical industry is changing at a rapid pace. This not only involves new medical developments, guidelines and corresponding equipment, but also the roles of all stakeholders. Uwe Harbauer, Senior Vice President of Bosch Packaging Technology’s Pharma Business Unit, shares his thoughts with us in a three-part interview. …more


Bosch and Klenzaids plan joint venture in India

Bosch Packaging Technology and Klenzaids Contamination Controls Pvt. Ltd. are planning a joint venture in India. Both companies signed agreements to this effect on November 28, 2014. The plan is for Bosch to acquire a 49 percent share in Klenzaids, an owner-managed company that produces processing, packaging, and clean-room technology for the global pharmaceutical industry. …more


Then and now – visionary tunnel technology

sterilization tunnel

The history of Bosch’s well-known sterilization tunnel began in the beginning of the 1970s. The engineer Ingbert Pennekamp was assigned to design a new tunnel for ampoules. In the greatest secrecy, the new model started taking shape in the assembly hall. Instead of developing the current equipment further, Ingbert Pennekamp set out to develop a groundbreaking technology. “It was our goal to provide customers with one solution for the entire process, thus facilitating their daily work,” Ingbert Pennekamp reports. The revolutionary result was a linear tunnel without any manual intermediate steps – at first with radiant heaters, later based on the laminar flow method for hot air sterilization. …more


Life-saving vaccines for children all over the world

Pharma Feature Vaccines

Dr. Cyrus S. Poonawalla believes that every child in the world should be granted access to inexpensive bacterial and viral vaccines. For this reason, he founded Serum Institute of India in 1966, which has ever since been supplying children all over the world with vaccines such as pentavalent and vaccines against MMR. …more


Top of page